[The effect of gingko biloba on cochleovestibulary pathology of vascular origin].
The AA. of the present paper recall the clinical and functional results of this therapy in a group of 70 patients complaining of vertigo. The Gingko biloba extract (4 ml/12 h per mouth) has been continued during 6 months. Neck and vertebrobasilar insufficiency were predominant causes. Six months later statistically significant changes regarding the decrease of intensity of tinnitus and vertigo crises were confirmed. Besides favorable alterations in the peripherical symptomatology as a relative hearing improvement turned up.
Cano Cuenca
B
B
Marco Algarra
J
J
Pérez del Valle
B
B
Pellicer Pascual
F J
FJ
D000328:Adult; D000368:Aged; D001301:Audiometry, Pure-Tone; D002545:Brain Ischemia / Q000150:complications*; D003051:Cochlea / Q000503:physiopathology*; D005260:Female; D006311:Hearing Disorders / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014717:Vertigo / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014722:Vestibule, Labyrinth / Q000503:physiopathology*
D010936:Plant Extracts
Efecto del Gingko biloba sobre la patología cocleovestibular de origen vascular.